Position in SCLX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$133
-$110 QoQ
Shares Held
20
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Operose Advisors LLC holds $4,210,580 across 12 Drug Manufacturers - General names. SCLX ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,825 | $1,049,389 | |
| 2 | JNJ |
Johnson & Johnson
|
3,236 | $791,007 | |
| 3 | LLY |
ELI LILLY & Co
|
856 | $787,323 | |
| 4 | PFE |
Pfizer Inc
|
25,412 | $713,568 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,030 | $605,058 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,044 | $145,502 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
838 | $50,824 | |
| 8 | AZN |
Astrazeneca PLC
|
151 | $29,780 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $133 | 20 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $243 | 20 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $393 | 20 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $117 | 20 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||